Results 211 to 220 of about 41,093 (226)
Some of the next articles are maybe not open access.
Stereotactic Radiotherapy for Vestibular Schwannoma
Otolaryngologic Clinics of North America, 2009Vestibular schwannomas are benign tumors of the Schwann cells of the eighth (VIII) cranial nerve. Precision radiotherapy techniques used to manage these tumors include stereotactic radiotherapy (SRT), which can be delivered with either a conventional or hypofractionated regimen.
Patrick, Sweeney +4 more
openaire +2 more sources
Stereotactic Body Radiotherapy/Stereotactic Ablative Body Radiotherapy for Lung Cancer
2013Technological advances in radiation oncology have led to clinical implementation of novel treatment modality. Stereotactic body radiotherapy (SBRT)/stereotactic ablative body radiotherapy (SABR) is an emerging treatment paradigm as a result of image-guidance technology and more sophisticated computational treatment planning system.
Hua Ren, Shanda Blackmon, Bin S. Teh
openaire +1 more source
Stereotactic radiotherapy for vestibular schwannoma
Cochrane Database of Systematic Reviews, 2014Vestibular schwannomas (acoustic neuromas) are common benign tumours that arise from the Schwann cells of the vestibular nerve. Management options include observation with neuroradiological follow-up, microsurgical resection and stereotactic radiotherapy.To assess the effect of stereotactic radiotherapy compared to observation, microsurgical resection,
Muzevic, Dario +3 more
openaire +3 more sources
Fractionated stereotactic radiotherapy for craniopharyngiomas
International Journal of Radiation Oncology*Biology*Physics, 2002To investigate outcome and toxicity after fractionated stereotactic radiation therapy (FSRT) in patients with craniopharyngiomas.Twenty-six patients with craniopharyngiomas were treated with FSRT between May 1989 and February 2001. Median age was 33.5 years (range: 5-57 years).
Daniela, Schulz-Ertner +5 more
openaire +2 more sources
Ultra-hypofractionated Radiotherapy (Stereotactic Body Radiotherapy)
2021Over the past two decades, interest in hypofractionated radiotherapy for prostate cancer has intensified. Research has indicated that prostate cancer cells may have a lower alpha/beta ratio than once supposed, and hypofractionation could widen the therapeutic window.
Michael C. Repka +7 more
openaire +1 more source
Stereotactic radiotherapy and oligometastases
The Lancet Oncology, 2021Fergus, Macbeth, Raymond, Abratt
openaire +2 more sources
Stereotactic radiotherapy of spinal hemangioblastoma
Burdenko's Journal of NeurosurgeryHemangioblastoma (HAB) is a benign, richly vascularized tumor that accounts for 2—6% of all spinal cord neoplasms and ranks third in the structure of intramedullary space-occupying lesions of the spinal cord. Hemangioblastoma may occur sporadically or, in approximately 30% of cases, as part of the clinical picture of a hereditary disease, von Hippel ...
A.I. Lestrovaya +5 more
openaire +2 more sources
[Stereotactic radiotherapy in brain metastases].
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique, 2015Stereotactic radiotherapy of brain metastases is increasingly proposed after polydisciplinary debates among experts. Its definition and modalities of prescription, indications and clinical interest regarding the balance between efficacy versus toxicity need to be discussed.
Dhermain, Frédéric +5 more
openaire +2 more sources
Stereotactic Radiotherapy for Lung Tumors
2014Early stage lung cancer may often be not amenable for surgery due to poor underlying lung function. While conventional radiation therapy may be utilized, respiratory motion often implies inclusion of large volumes of normal lung, to cover the planning target volume with the attending morbidity.
openaire +2 more sources